Giuseppe M.C. Rosano

President Heart Failure Association Giuseppe M.C. Rosano, MD, PhD, is Director of the Cardiovascular translational laboratory at IRCCS San Raffaele Roma where he is also Professor of Pharmacology and Consultant Cardiologist. G.R. received his medical degree and his specialisation in cardiovascular medicine from “La Sapienza” University of Rome in Rome, Italy, and his PhD in Medical Sciences from the Imperial College of Science and Technology in London, United Kingdom. G.R. has served as member of the CVWP of the European Medicines Agency since July 2020, he has been board member of the Italian Space Agency and member of the pricing and reimbursement committee at the Italian Drug Agency. G.R. is fellow of the European Society of Cardiology, the Heart Failure Association, the American College of Cardiology, and the Italian Federation of Cardiology. He serves as Editorial Board Member for European Heart Journal, European Journal of Heart Failure, European Heart Journal—Cardiovascular Pharmacotherapy, ESC Heart Failure, Cardiovascular Diabetology, Nature Research Scientific Reports, Cardiovascular Reviews, Advances in Therapy, European Cardiology Review, and Climacteric. G.R. has authored or co-authored more than 600 peer-reviewed articles. He is the president of the Heart Failure Association of the ESC.

Curriculum Vitae

Giuseppe Massimo Claudio Rosano is a distinguished international authority in cardiovascular medicine, regulatory science, and pharmacology. He serves as a Professor of Cardiology and Consultant Cardiologist at St George’s University of London and St George’s Hospitals NHS Trust. Concurrently, he maintains prominent academic ties in Italy as a Professor of Pharmacology and serves as a vital medical director.

Throughout his prolific career, Professor Rosano has accumulated extraordinary expertise in regulatory and committee spheres, notably serving as the Past-President of the Heart Failure Association of the ESC, a long-standing member of the Cardiovascular Working Party at the European Medicines Agency (EMA), and a senior board member for the Italian Drug Agency (AIFA). With over 820 publications, a remarkable H-index of 131, and more than 85,000 citations, his professional focus centers on clinical trial assessment, molecular medicine pathways, and metabolic-endocrine cardiovascular conditions.

Partecipazioni del relatore

Essential Concepts in Cardiopulmonary Medicine: Hypertension, Heart Failure, Ischemic Heart Disease and Respiratory Illness

Nessun topic

Essential Concepts in Cardiopulmonary Medicine: Hypertension, Heart Failure, Ischemic Heart Disease and Respiratory Illness

Cape Town | Da 08/03/2024 a 09/03/2024

Gratuita

Scopri corso

Advances in heart failure, cardiomyopathies and pericardial diseases

Nessun topic

Advances in heart failure, cardiomyopathies and pericardial diseases

Trieste | Da 22/04/2022 a 23/04/2022

Gratuita

Scopri corso

International Symposium: Cardiometabolic Risk and Vascular Disease from Mechanisms to Treatment

CARDIOLOGIA

International Symposium: Cardiometabolic Risk and Vascular Disease from Mechanisms to Treatment

Stoccolma | Da 20/09/2021 a 21/09/2021

Gratuita

Scopri corso

Impact of COVID-19 on cardiovascular disease and healthcare organisation IN EUROPE

CARDIOLOGIA

Impact of COVID-19 on cardiovascular disease and healthcare organisation IN EUROPE

Online | Da 22/10/2020 a 26/10/2020

Gratuita

Scopri corso

2019 Esc Guidelines on the Management of Chronic Coronary Syndromes: a Critical Approach

CARDIOLOGIA

2019 Esc Guidelines on the Management of Chronic Coronary Syndromes: a Critical Approach

Atene | Da 27/09/2019 a 28/09/2019

Gratuita

Scopri corso

International Cardiovascular Symposium on: Cardiac & Vascular Diseases

Nessun topic

International Cardiovascular Symposium on: Cardiac & Vascular Diseases

Varsavia | Da 14/06/2019 a 15/06/2019

Gratuita

Scopri corso

Giuseppe M.C. Rosano